Amneal Pharmaceuticals, Inc.
AMRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $18 | $36 | $25 | -$21 |
| Dep. & Amort. | $54 | $60 | $60 | $66 |
| Deferred Tax | -$23 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $8 | $7 | $7 |
| Change in WC | -$51 | -$35 | -$106 | $22 |
| Other Non-Cash | $112 | $15 | $22 | $44 |
| Operating Cash Flow | $118 | $84 | $7 | $118 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22 | -$27 | -$13 | -$22 |
| Net Acquisitions | $0 | $1 | $0 | $7 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$5 | -$1 |
| Investing Cash Flow | -$22 | -$27 | -$18 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $67 | -$17 | -$18 | -$56 |
| Stock Issued | $1 | $1 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8 | -$25 | -$22 | -$6 |
| Financing Cash Flow | $59 | -$42 | -$39 | -$61 |
| Forex Effect | -$1 | -$0 | -$0 | -$1 |
| Net Chg. in Cash | $155 | $15 | -$50 | $40 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $81 | $66 | $118 | $78 |
| End Cash | $236 | $81 | $68 | $118 |
| Free Cash Flow | $103 | $57 | -$11 | $95 |